Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » NASH

NASH

ADVERTISEMENT
More News!

Alimentiv and Summit collaborate to tackle liver disease NASH

Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit…

By Liza Laws
November 4, 2022 - 3 minutes
More News!

Strategic collaboration for drug to treat NASH, obesity and diabetes announced

A conditional and exclusive license agreement to develop and commercialize a drug to treat nonalcoholic…

By Liza Laws
September 16, 2022 - 4 minutes
News and Trends

Poxel publishes ALD studies

Two preclinical articles have been published in different journals for treatments being developed by French…

By Liza Laws
July 5, 2022 - 3 minutes
In Depth

Is a Treatment for NASH Finally on the Horizon?

Despite several high-profile trial failures in the field, multiple players are getting close to the…

By Clara Rodríguez Fernández
March 2, 2022 - 6 minutes
Sponsored by Medpace

Infographic: The Key Role of Imaging in Clinical Trials

Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have…

By Maya Chergova
January 26, 2021 - 2 minutes
News and Trends

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

Patients with the chronic liver disease NASH must now wait even longer for an approved…

By Helen Albert
May 13, 2020 - 4 minutes
News and Trends

NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial

The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund…

By Jonathan Smith
January 8, 2020 - 2 minutes
News and Trends

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…

By Jonathan Smith
December 17, 2019 - 2 minutes
Sponsored

Treating Liver Diseases: Is This Preclinical Model the Solution?

Liver diseases are on the rise. Although many drug candidates are being developed, preclinical toxicity,…

By Larissa Warneck-Silvestrin
December 4, 2019 - 6 minutes
Sponsored

Can This Cell Therapy Help Fight the NASH Epidemic?

Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) and…

By Larissa Warneck-Silvestrin
November 4, 2019 - 7 minutes
Interview

The First Approved NASH Therapy?

Genfit is poised to become the first company to get a treatment for NASH to…

By Helen Albert
July 30, 2019 - 6 minutes
News and Trends

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M

The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for…

By Jonathan Smith
June 25, 2019 - 3 minutes
  • 1
  • 2
  • 3
  • 4
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days